<DOC>
	<DOCNO>NCT00975962</DOCNO>
	<brief_summary>This study blind randomize study . Randomization treatment/not treatment remote perconditioning take place transportation hospital . This investigator ' hypothesis state remote perconditioning neuro-protective effect proportionally large early treatment . As size effect unknown , investigator use multiple magnetic resonance imaging ( MRI ) scan determine size potential neuro-protective effect . The aim study : 1 . To describe method remote perconditioning clinical practice regard feasibility . Pros con potential limitation . 2 . To estimate size effect remote perconditioning combination recombinant tissue plasminogen activator ( rtPa ) treatment within four half hour onset symptom .</brief_summary>
	<brief_title>New Acute Treatment Stroke - The Effect Remote PERconditioning</brief_title>
	<detailed_description>Final inclusion inform consent take place first MRI patient eligible rtPA . Follow-up MRI 24h 1 month . Clinical outcome 3 month .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Tissue Plasminogen Activator</mesh_term>
	<criteria>Significant ischemic stroke suspicion ( NIHSS 124 ) paresis extremity . Treatment rtPa within 4.5 hour debut symptom . Age 18 ( change 01.01.2010 upper age limit ) Independent daily live acute onset symptom . ( mrs &lt; /=2 ) MR scan showing DWI lesion , consistent acute ischemic stroke . Contraindications iv rtPA Onset symptom older 4.5 hour Previous disease brain : Intracranial aneurism arteriovenous malformation . Brain surgery hemorrhagic stroke . Former ischemic stroke within last 3 month . Heart diseases : Infectious endocarditis suspicion septic embolus , pericarditis , ventricular thrombosis , aneurisms heart wall major heart failure . Serious disease : Cancer , AIDS , dementia , significant abuse , renal failure , liver disease liver failure , cirrhosis , portal hypertension , active hepatitis . Pregnancy Major ischemic stroke patient unconscious . ( NIHSS &gt; 25 ) . Symptoms suspect migraine , Multiple sclerosis , TIA another neurological disease ischemic stroke . MR scan : Contraindications MRI scan Tumor cerebri , cerebral abscess Known hypersensitivity Gadovist ingredient , acute chronic severe renal impairment ( GFR &lt; 30 ml/min/1.73m2 ) , acute renal insufficiency severity due hepatorenal syndrome perioperative liver transplantation period . Caution use Gadovist patient severe cardiovascular disease , use riskbenefit assessment . Caution use Gadovist patient low threshold seizure . Lab data : Blood glucose &lt; 2 , 8 mmol/l &gt; 22 mmol/l</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Stroke</keyword>
	<keyword>Neuroprotection</keyword>
	<keyword>remote preconditioning</keyword>
	<keyword>Salvage index ( % ) : Difference infarct growth ( PWI-DWI )</keyword>
</DOC>